华康生物医学(08622)股东将股票由擎天证券转入金利丰证券 转仓市值5483.86万港元
HUAKANG BIOMEDHUAKANG BIOMED(HK:08622) 智通财经网·2025-10-10 00:52

Group 1 - The core point of the article is the transfer of shares of Huakang Biomedical (08622) from Qingtian Securities to Jinlifeng Securities, with a market value of HKD 54.83 million, representing 27.74% of the total shares [1] - On October 9, Huakang Biomedical and the offeror Anselme Limited announced a conditional agreement for the sale of 138.7 million shares, which constitutes approximately 27.71% of the company's total issued share capital as of the announcement date [1] - The total consideration for the shares is HKD 17.47 million, equating to a price of HKD 0.126 per share [1]